Prestige Consumer Healthcare Inc. (PBH) Financial Ratios
25 years of historical data (2001–2025) · Healthcare · Medical - Distribution
EV/EBITDA
↑
9.62
↓-90% vs avg
5yr avg: 96.81
30Y Low7.7·High33.5
P/FCF
↑
10.62
↓-22% vs avg
5yr avg: 13.64
30Y Low3.9·High20.5
P/B Ratio
↑
1.49
↓-26% vs avg
5yr avg: 2.01
30Y Low0.9·High3.8
ROE
↓
12.3%
↓+30% vs avg
5yr avg: 9.5%
30Y Low-48%·High34%
Debt/EBITDA
↓
2.85
↓-90% vs avg
5yr avg: 29.72
30Y Low2.8·High18.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PBH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Prestige Consumer Healthcare Inc. trades at 12.7x earnings, 21% below its 5-year average of 16.0x, sitting at the 12th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 43%. On a free-cash-flow basis, the stock trades at 10.6x P/FCF, 22% below the 5-year average of 13.6x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.6B | $4.3B | $3.6B | $3.1B | $2.7B | $2.2B | $1.9B | $1.6B | $1.8B | $3.0B | $2.8B |
| Enterprise Value | $3.5B | $5.3B | $4.7B | $4.4B | $4.2B | $3.7B | $3.5B | $3.3B | $3.8B | $5.1B | $4.4B |
| P/E Ratio → | 12.72 | 20.04 | 17.40 | — | 13.10 | 13.56 | 13.19 | — | 5.32 | 42.74 | 28.40 |
| P/S Ratio | 2.27 | 3.78 | 3.24 | 2.77 | 2.48 | 2.36 | 1.95 | 1.60 | 1.73 | 3.36 | 3.52 |
| P/B Ratio | 1.49 | 2.35 | 2.20 | 2.16 | 1.71 | 1.64 | 1.60 | 1.42 | 1.53 | 3.60 | 3.81 |
| P/FCF | 10.62 | 17.70 | 15.21 | 14.08 | 10.75 | 10.45 | 9.26 | 8.71 | 9.14 | 20.48 | 16.61 |
| P/OCF | 10.27 | 17.12 | 14.63 | 13.60 | 10.36 | 9.47 | 8.64 | 8.23 | 8.59 | 20.06 | 16.27 |
P/E links to full P/E history page with 30-year chart
PBH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Prestige Consumer Healthcare Inc.'s enterprise value stands at 9.6x EBITDA, 90% below its 5-year average of 96.8x. The Healthcare sector median is 14.4x, placing the stock at a 33% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.62 | 4.21 | 3.93 | 3.84 | 3.94 | 3.68 | 3.41 | 3.62 | 5.80 | 5.50 |
| EV / EBITDA | 9.62 | 14.31 | 12.69 | 434.20 | 11.52 | 11.34 | 10.79 | 33.52 | 15.10 | 22.11 | 15.62 |
| EV / EBIT | 10.48 | 15.83 | 13.79 | — | 12.76 | 12.96 | 12.33 | 49.66 | 11.68 | 25.03 | 18.29 |
| EV / FCF | — | 21.59 | 19.78 | 19.98 | 16.66 | 17.40 | 17.51 | 18.61 | 19.06 | 35.34 | 25.97 |
PBH Profitability
Margins and return-on-capital ratios measuring operating efficiency
Prestige Consumer Healthcare Inc. earns an operating margin of 29.6%. Operating margins have expanded from -2.0% to 29.6% over the past 3 years, signaling improving operational efficiency. ROE of 12.3% is modest. ROIC of 9.1% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.8% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 57.9% |
| Operating Margin | 29.6% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% |
| Net Profit Margin | 18.9% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.3% | 12.3% | 13.5% | -5.4% | 14.0% | 13.0% | 12.6% | -3.1% | 33.9% | 8.9% | 14.6% |
| ROA | 6.4% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -1.0% | 8.9% | 2.0% | 3.6% |
| ROIC | 9.1% | 9.1% | 9.3% | -0.6% | 8.4% | 7.8% | 7.6% | 1.7% | 5.3% | 5.8% | 8.6% |
| ROCE | 10.4% | 10.4% | 10.7% | -0.7% | 9.7% | 8.9% | 8.7% | 1.9% | 5.8% | 6.2% | 9.6% |
PBH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Prestige Consumer Healthcare Inc. carries a Debt/EBITDA ratio of 2.8x, which is moderately leveraged (13% below the sector average of 3.3x). Net debt stands at $946M ($1.0B total debt minus $98M cash). Interest coverage of 7.1x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.57 | 0.57 | 0.69 | 0.94 | 0.95 | 1.12 | 1.51 | 1.64 | 1.69 | 2.67 | 2.18 |
| Debt / EBITDA | 2.85 | 2.85 | 3.05 | 133.90 | 4.16 | 4.62 | 5.37 | 18.12 | 7.99 | 9.48 | 5.72 |
| Net Debt / Equity | — | 0.52 | 0.66 | 0.90 | 0.94 | 1.09 | 1.43 | 1.62 | 1.66 | 2.62 | 2.15 |
| Net Debt / EBITDA | 2.58 | 2.58 | 2.93 | 128.17 | 4.09 | 4.53 | 5.08 | 17.84 | 7.86 | 9.30 | 5.63 |
| Debt / FCF | — | 3.89 | 4.57 | 5.90 | 5.91 | 6.95 | 8.25 | 9.91 | 9.92 | 14.86 | 9.36 |
| Interest Coverage | 7.07 | 7.07 | 5.10 | -0.32 | 5.13 | 3.61 | 3.02 | 0.64 | 2.03 | 2.20 | 3.05 |
PBH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Prestige Consumer Healthcare Inc.'s current ratio of 4.20x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.82x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 2.44x to 4.20x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.20 | 4.20 | 3.20 | 2.44 | 2.04 | 2.21 | 2.44 | 2.37 | 2.46 | 2.06 | 2.33 |
| Quick Ratio | 2.82 | 2.82 | 2.02 | 1.43 | 1.21 | 1.27 | 1.67 | 1.43 | 1.50 | 1.35 | 1.48 |
| Cash Ratio | 0.92 | 0.92 | 0.40 | 0.36 | 0.19 | 0.26 | 0.63 | 0.22 | 0.26 | 0.26 | 0.26 |
| Asset Turnover | — | 0.33 | 0.34 | 0.34 | 0.30 | 0.28 | 0.27 | 0.28 | 0.28 | 0.23 | 0.27 |
| Inventory Turnover | 3.41 | 3.41 | 3.61 | 3.10 | 3.87 | 3.44 | 3.54 | 3.51 | 3.92 | 3.30 | 3.71 |
| Days Sales Outstanding | — | 62.33 | 57.34 | 54.06 | 46.79 | 44.37 | 57.05 | 55.66 | 49.39 | 56.58 | 43.12 |
PBH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Prestige Consumer Healthcare Inc. returns 2.0% to shareholders annually primarily through share buybacks. The earnings yield of 7.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.9% | 5.0% | 5.7% | — | 7.6% | 7.4% | 7.6% | — | 18.8% | 2.3% | 3.5% |
| FCF Yield | 9.4% | 5.7% | 6.6% | 7.1% | 9.3% | 9.6% | 10.8% | 11.5% | 10.9% | 4.9% | 6.0% |
| Buyback Yield | 2.0% | 1.2% | 0.7% | 1.6% | 0.0% | 0.5% | 3.0% | 3.2% | 0.1% | 0.0% | 0.1% |
| Total Shareholder Yield | 2.0% | 1.2% | 0.7% | 1.6% | 0.0% | 0.5% | 3.0% | 3.2% | 0.1% | 0.0% | 0.1% |
| Shares Outstanding | — | $50M | $50M | $50M | $51M | $51M | $51M | $52M | $54M | $53M | $53M |
Peer Comparison
Compare PBH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PBHYou | $3B | 12.7 | 9.6 | 10.6 | 55.8% | 29.6% | 12.3% | 9.1% | 2.8 |
 SPB | $2B | 20.4 | 10.6 | 11.0 | 36.7% | 4.4% | 4.9% | 3.9% | 2.9 |
 CHD | $22B | 31.1 | 18.1 | 20.3 | 44.7% | 17.4% | 17.6% | 13.9% | 1.7 |
 ENR | $1B | 5.6 | 7.0 | 20.1 | 40.6% | 17.8% | 156.4% | 11.8% | 5.4 |
 PRGO | $2B | -1.1 | 7.4 | 11.1 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
 COTY | $2B | -5.7 | 9.4 | 7.9 | 64.8% | 4.1% | -9.0% | 2.3% | 6.4 |
 KVUE | $34B | 23.3 | 12.7 | 19.8 | 58.1% | 17.9% | 14.4% | 11.4% | 2.6 |
 HLN | $41B | 19.1 | 13.6 | 15.5 | 64.8% | 22.4% | 10.0% | 7.6% | 3.1 |
 HIMS | $7B | 50.3 | 42.7 | 89.6 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 GDRX | $973M | 33.3 | 4.0 | 5.9 | 82.1% | 13.4% | 4.5% | 13.0% | 0.3 |
 USPH | $897M | 41.5 | 12.5 | 14.7 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 25 years · Updated daily
See PBH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PBH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PBH vs SPB
Side-by-side business, growth, and profitability comparison vs Spectrum Brands Holdings, Inc..
Start ComparisonPBH — Frequently Asked Questions
Quick answers to the most common questions about buying PBH stock.
What is Prestige Consumer Healthcare Inc.'s P/E ratio?
Prestige Consumer Healthcare Inc.'s current P/E ratio is 12.7x. The historical average is 19.5x. This places it at the 12th percentile of its historical range.
What is Prestige Consumer Healthcare Inc.'s EV/EBITDA?
Prestige Consumer Healthcare Inc.'s current EV/EBITDA is 9.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.8x.
What is Prestige Consumer Healthcare Inc.'s ROE?
Prestige Consumer Healthcare Inc.'s return on equity (ROE) is 12.3%. The historical average is 5.9%.
Is PBH stock overvalued?
Based on historical data, Prestige Consumer Healthcare Inc. is trading at a P/E of 12.7x. This is at the 12th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Prestige Consumer Healthcare Inc.'s profit margins?
Prestige Consumer Healthcare Inc. has 55.8% gross margin and 29.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Prestige Consumer Healthcare Inc. have?
Prestige Consumer Healthcare Inc.'s Debt/EBITDA ratio is 2.8x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.